Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Mindfulness in PREventing Progression to Psychosis in Individuals With an Ultra High Risk for Psychosis

NCT06870305 is registered in ClinicalTrials.gov with Centre Psychothérapique de Nancy as lead sponsor.

NCT NCT06870305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06870305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Mindfulness in PREventing Progression to Psychosis in Individuals With an Ultra High Risk for Psychosis
Lead sponsor
Centre Psychothérapique de Nancy
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 30, 2029
Completion date
December 31, 2029
Enrollment
270 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

clinical high risk for psychosis (chr)